Enorama Pharma AB (ERMA) — Cash Flow Reinvestment Rate

Latest as of December 2015: 0.00x

Enorama Pharma AB (ERMA) has a Cash Flow Reinvestment Rate of 0.00x as of December 2015, reinvesting Skr0.00 (capex Skr0.00 ) from operating cash flow of Skr760.00K. Explore Enorama Pharma AB (ERMA) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

Skr0.00
Capex + Investments

Operating Cash Flow

Skr760.00K
SEK

Capital Expenditures

Skr0.00
SEK

Enorama Pharma AB Cash Flow Reinvestment Rate (2014–2015)

Historical reinvestment intensity for Enorama Pharma AB across 2 annual periods. Also explore ERMA current and non-current assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Enorama Pharma AB (2014–2015)

Year-by-year capital reinvestment analysis for Enorama Pharma AB. For live market cap and broader valuation context, see Enorama Pharma AB (ERMA) total market value.

Year Reinvestment Rate Total Reinvested (SEK) Operating CF Capex YoY Change
2015 4.15x Skr1.99 Million Skr480.00K Skr1.99 Million ▼ -7.8%
2014 4.50x Skr1.38 Million Skr307.00K Skr1.38 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow